Benzofused-N-containing heterocycle derivatives

Pharmacologically active benzofused-N-containing heterocycle derivatives are described as muscarinic receptor blocking agents useful for the treatment of gastrointestinal and respiratory tract disorders of the following formula: wherein R represents H or C1-6 alkyl; R1 and R2 represent H, halogen, C...

Full description

Saved in:
Bibliographic Details
Main Authors SCHIAVI, BATTISTA GIOVANNI, TURCONI, MARCO, SAGRADA, ANGELO, DONETTI, ARTURO, DOODS, HENRI NICO, MICHELETTI, ROSAMARIA
Format Patent
LanguageEnglish
French
German
Published 27.12.1995
Edition5
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Pharmacologically active benzofused-N-containing heterocycle derivatives are described as muscarinic receptor blocking agents useful for the treatment of gastrointestinal and respiratory tract disorders of the following formula: wherein R represents H or C1-6 alkyl; R1 and R2 represent H, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 alkoxycarbonyl, carboxyl, hydroxy, nitro, cyano, optionally C1-4 alkyl mono- or disubstituted carbamoyl, optionally C1-4 alkyl mono- or disubstituted amino, C1-6 acylamino, C1-4 alkoxy carbonylamino, C1-6 alkylsulphynyl, C1-6 alkylsulphonyl, C1-6 acyl; R3 represents H, C1-6 alkyl, aryl, aralkyl or it may be absent; A represents CO, C = S, S -> O or B represents nitrogen when R3 is absent and the B-D bond is single, or it is carbon; D represents CO, CH2-CH2, when the B-D bond is single, or D is C-R when the D-B bond is double, in which R4 represents H, C1-6 alkyl, aryl, aralkyl, hydroxy, C1-4 alkoxy and R5 represents H; X represents oxygen, N-R or it is absent; Y represents a basic group selected from: in which n is 2 or 3; p is 0 or 1 at the same time or not; q is 0, 2 or 3; R6 and R7 may be at the same time or not H, C1-4 alkyl, aralkyl or, when R7 is H or C1-4 alkyl, R6 may be in which R8 represents H, C1-4 alkyl or amino. The processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described.
Bibliography:Application Number: EP19900830040